Genelux (GNLX) Payables (2022 - 2026)
Genelux's (GNLX) quarterly Payables came in at $6.1 million in Q1 2026, up 39.86% quarter-over-quarter from $4.4 million in Q4 2025.
Genelux (GNLX) Payables (2022 - 2026) Analysis & Trends
Genelux's Payables history runs 5 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- On a quarterly basis, Payables changed N/A year-over-year to $6.1 million in Q1 2026; TTM through Mar 2026 was $6.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.4 million, down 21.76% from the prior year.
- Payables advanced to $6.1 million in Q1 2026 per GNLX's latest filing, from $4.4 million in the prior quarter.
- Across five years, Payables topped out at $7.8 million in Q4 2022 and bottomed at $3.8 million in Q4 2023.
- The 5-year median for Payables is $4.8 million (2024), against an average of $5.1 million.
- Across the five-year window, Payables sank 50.77% in 2023 and surged 45.66% in 2024, its largest moves.
- Year by year, Payables stood at $7.8 million in 2022, then sank by 50.77% to $3.8 million in 2023, then jumped by 45.66% to $5.6 million in 2024, then declined by 21.76% to $4.4 million in 2025, then jumped by 39.86% to $6.1 million in 2026.
- Per Business Quant, the three latest GNLX Payables figures stand at $6.1 million (Q1 2026), $4.4 million (Q4 2025), and $4.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.69 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 80.54 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.10 Mn |
| Dec 31, 2025 | 4.36 Mn |
| Sep 30, 2025 | 3.99 Mn |
| Jun 30, 2025 | 6.03 Mn |
| Dec 31, 2024 | 5.57 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 4.79 Mn |
| Mar 31, 2024 | 5.31 Mn |
| Dec 31, 2023 | 3.82 Mn |
| Sep 30, 2023 | 4.05 Mn |
| Dec 31, 2022 | 7.77 Mn |